Login
← Go Back
Dr. Reddy's Laboratories
DRREDDY · Pharma > Pharmaceuticals & Drugs · Chairman: K Satish Reddy · MD: GV Prasad · Listing date: Oct. 24, 1994 · Employees: 22739 · Hyderabad · http://www.drreddys.com
Stock Price vs Company Growth
1d
1.4%
1w
0.9%
1m
0.6%
3m
0.3%
6m
2.0%
1y
15.8%
5y
8.1%
10y
8.0%
all
12.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,275 1.4%
1,149
1,336
Company Overview
Sales
34,682 Cr
Growth: 12.1%
Profit after Tax
5,568 Cr
Growth: -3.5%
Large Cap
1,06,422 Cr
P/E: 19.1x
Industry P/E: 27.6x
Fundamentals
Sales (Cr) ₹ 34,682
Growth 12.1%
EBITDA 23.3%
P/S 3.1x
Dividend 0.6%
P/E 19.1x
Book Value ₹ 450
PEG Ratio 1.6x
ROE 15.6%
P/B 2.8x
Shareholding Pattern
Institutions
First Senter Investors Icvc- Stewart Investors Asia Pacific Leaders Sustainability Fund
3.37 %
Life Insurance Corporation Of India P & Gs Fund
2.34 %
Sbi Mutual Fund
2.11 %
Aditya Birla Mutual Fund
1.96 %
Government Of Singapore - E
1.77 %
Promoters
Dr. Reddy'S Holdings Limited
24.84 %
Gunupati Venkateswara Prasad (Huf)
0.67 %
Samrajyam Reddy Kallam
0.67 %
Satish Reddy Kallam
0.54 %
Others
Jp Morgan Chase Bank, Na
12.09 %
Icici Prudential Life Insurance Company Limited
1.38 %
Nps Trust - A/C
1.27 %
Iepf
0.14 %
Increase    Decrease    No change
Company Profile Detailed
The company is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Belongs to (57 Indices) view more
Investors (387)
sbi.mutu...
sanjay.c...
bryan.di...
Followers (34)
manzoor
talent
apurv